Uni-Bio Science Group Limited (0690.HK)
HKD 0.08
(10.29%)
HKD 0.08
(10.29%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 99.41 Million | 48.66 Million | 12.04 Million | -15.47 Million | -30.74 Million | -89 Million |
| Net Income | 70.87 Million | 43.28 Million | -20.01 Million | -70.94 Million | 5.14 Million | -138.43 Million |
| Depreciation & Amortization | 16.88 Million | 17.54 Million | 20.85 Million | 20.92 Million | 21.48 Million | 21.75 Million |
| Deferred income taxes | - | - | 13.55 Million | 34.39 Million | -66.62 Million | 19.18 Million |
| Stock-based compensation | - | 543 Thousand | 3.93 Million | 10.89 Million | 8.34 Million | 8.55 Million |
| Change in working capital | 9.08 Million | -11.3 Million | -5.99 Million | -9.56 Million | 971 Thousand | 772 Thousand |
| Other non-cash items | 30.28 Million | -1.41 Million | -297 Thousand | -1.17 Million | -64 Thousand | -831 Thousand |
| Investing Cash Flow | -77.49 Million | -27.02 Million | 42.12 Million | -24.64 Million | 51.05 Million | 89.83 Million |
| Investments in PPE | -59.73 Million | -28.43 Million | -8.43 Million | -12.97 Million | -9.25 Million | -2.75 Million |
| Acquisitions | - | 104 Thousand | 17 Thousand | 9.53 Million | 18.78 Million | - |
| Investment purchases | - | - | -17 Thousand | -67.61 Million | -49 Million | - |
| Sales/Maturities of investments | - | - | 36.36 Million | 55.38 Million | 35 Million | 91.51 Million |
| Other Investing Activities | -17.75 Million | 1.29 Million | 14.19 Million | -8.97 Million | 55.51 Million | 92.59 Million |
| Financing Cash Flow | 25.29 Million | 2.57 Million | 478 Thousand | -5.4 Million | 13.87 Million | 13.2 Million |
| Debt repayment | -30.78 Million | -11.62 Million | -678 Thousand | -350 Thousand | -13.44 Million | -13.44 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -5.16 Million | - | -6.01 Million | -4.98 Million | - | - |
| Common Stock Issuance | - | - | - | - | 29.99 Million | - |
| Other Financing Activities | 3.61 Million | 14.2 Million | 7.16 Million | -73 Thousand | -2.67 Million | 13.2 Million |
| Accounts receivables | -1.07 Million | 823 Thousand | 14.46 Million | -12.9 Million | -33.28 Million | 25.12 Million |
| Accounts payables | 11.52 Million | -13.9 Million | -4.28 Million | 12.98 Million | 21.85 Million | -17.73 Million |
| Inventory | -4.39 Million | 2.07 Million | -23.19 Million | -3.18 Million | 5.17 Million | -4.96 Million |
| Other working capital | 3.02 Million | -295 Thousand | 7.02 Million | -6.46 Million | 7.21 Million | 5.74 Million |
| Cash at beginning of period | 98.21 Million | 83.6 Million | 25.01 Million | 66.19 Million | 31.78 Million | 22.76 Million |
| Cash at end of period | 129.23 Million | 98.21 Million | 83.6 Million | 25.01 Million | 66.19 Million | 31.78 Million |
| Capital Expenditure | -59.73 Million | -28.43 Million | -8.43 Million | -12.97 Million | -9.25 Million | -2.75 Million |
| Effect of forex changes on cash | -16.19 Million | -9.59 Million | 3.95 Million | 4.34 Million | 230 Thousand | -5.01 Million |
| Net cash flow / Change in cash | 31.01 Million | 14.6 Million | 58.59 Million | -41.18 Million | 34.41 Million | 9.02 Million |
| Free Cash Flow | 39.67 Million | 20.23 Million | 3.6 Million | -28.45 Million | -40 Million | -91.75 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 33.69 Million | 33.69 Million | 31.47 Million | 70.87 Million | 15.73 Million | 39.4 Million |
| Depreciation & Amortization | 5.46 Million | 5.46 Million | 9.14 Million | 16.88 Million | 4.35 Million | 7.74 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -2.73 Million | 9.08 Million | -2.73 Million | - |
| Other non-cash items | -12.12 Million | -12.12 Million | 46.72 Million | 30.28 Million | 16.88 Million | -1.29 Million |
| Investing Cash Flow | -17.9 Million | -17.9 Million | -57.77 Million | -77.49 Million | -28.21 Million | -19.72 Million |
| Investments in PPE | - | - | -29.86 Million | -59.73 Million | -29.86 Million | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -17.9 Million | -17.9 Million | 1.65 Million | -17.75 Million | 1.65 Million | -9.86 Million |
| Financing Cash Flow | 12.66 Million | 12.66 Million | 24.65 Million | 25.29 Million | 11.93 Million | 643 Thousand |
| Debt repayment | - | - | - | -30.78 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -2.58 Million | -5.16 Million | -2.58 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 12.66 Million | 12.66 Million | 14.51 Million | 3.61 Million | 14.51 Million | 321.5 Thousand |
| Accounts receivables | - | - | -536 Thousand | -1.07 Million | -536 Thousand | - |
| Accounts payables | - | - | - | 11.52 Million | - | - |
| Inventory | - | - | -2.19 Million | -4.39 Million | -2.19 Million | - |
| Other working capital | - | - | - | 3.02 Million | - | - |
| Cash at beginning of period | 129.23 Million | - | 95.83 Million | 98.21 Million | - | 98.21 Million |
| Cash at end of period | 153.96 Million | 12.36 Million | 129.23 Million | 129.23 Million | 16.7 Million | 95.83 Million |
| Capital Expenditure | - | - | -29.86 Million | -59.73 Million | -29.86 Million | - |
| Effect of forex changes on cash | -9.43 Million | -9.43 Million | -1.26 Million | -16.19 Million | -1.26 Million | -6.83 Million |
| Net cash flow / Change in cash | 24.72 Million | 12.36 Million | 33.4 Million | 31.01 Million | 16.7 Million | -2.38 Million |
| Free Cash Flow | 27.03 Million | 27.03 Million | 39.18 Million | 39.67 Million | 4.37 Million | 30.36 Million |
8940
ASTO
CEADW
0095
EDUCOMP
ISGI